News
09-01-2010, 09:40 PM
PDL BioPharma, Inc. today announced revenue guidance for the third quarter ended September 30, 2010 of approximately $86 million, as compared with actual results of $71.4 million for the third quarter of 2009, a 20 percent year-over-year increase.
More... (http://www.news-medical.net/news/20100902/PDL-BioPharma-reports-revenue-guidance-of-2486-million-for-2010-third-quarter.aspx)
More... (http://www.news-medical.net/news/20100902/PDL-BioPharma-reports-revenue-guidance-of-2486-million-for-2010-third-quarter.aspx)